Prevalence of SARS-CoV-2 Viremia in Presymptomatic Blood Donors in the Delta and Omicron Variant Eras-Reference-Cited by-同舟云学术

Prevalence of SARS-CoV-2 Viremia in Presymptomatic Blood Donors in the Delta and Omicron Variant Eras

Published:2023-05 Issue:5 Volume:10 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Saá Paula¹,Fink Rebecca V²,Dawar Hina³,Di Germanio Clara³⁴,Montalvo Leilani³,Wright David J²,Krysztof David E¹,Kleinman Steven H⁵,Nester Theresa⁶,Kessler Debra A⁷,Townsend Rebecca L¹,Spencer Bryan R¹,Kamel Hany⁸,Vannoy Jackie⁸,Busch Michael P³⁴,Stramer Susan L¹,Stone Mars³⁴^ORCID,Norris Philip J³⁴⁹^ORCID,

Affiliation:

1. Scientific Affairs, American Red Cross , Rockville, Maryland , USA

2. Westat , Rockville, Maryland , USA

3. Vitalant Research Institute , San Francisco, California , USA

4. Department of Laboratory Medicine, University of California San Francisco , San Francisco, California , USA

5. University of British Columbia , Victoria, British Columbia , Canada

6. Bloodworks Northwest , Seattle, Washington , USA

7. New York Blood Center Enterprises , New York, New York , USA

8. Vitalant , Scottsdale, Arizona , USA

9. Department of Medicine, University of California San Francisco , San Francisco, California , USA

Abstract

Abstract Presymptomatic plasma samples from 1596 donors reporting coronavirus disease 2019 infection or symptoms after blood donation were tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA and anti-S and anti-N antibodies. Prior infection and vaccination both protected from developing SARS-CoV-2 RNAemia and from symptomatic infection. RNAemia rates did not differ in the Delta and Omicron variant eras.

Funder

National Heart, Lung, and Blood Institute

National Institute of Allergies and Infectious Diseases

NIH

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

https://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofad253/50257419/ofad253.pdf

Reference14 articles.

1. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections;Stacey;J Virol,2009

2. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection;Keele;Proc Natl Acad Sci U S A,2008

3. Cytokine and chemokine responses in the acute phase of hepatitis B virus replication in naive and previously vaccinated blood and plasma donors;Keating;J Infect Dis,2014

4. Frequent detection but lack of infectivity of SARS-CoV-2 RNA in presymptomatic, infected blood donor plasma;Saá;J Clin Invest,2022

5. SARS-Cov-2 antibody persistence in COVID-19 convalescent plasma donors: dependency on assay format and applicability to serosurveillance;Di Germanio;Transfusion,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of transfusion‐transmitted infection with severe acute respiratory syndrome coronavirus 2 from blood donors in Japan;Transfusion;2023-12-13